CORZIDE - 60793-284-01 - (nadolol and bendroflumethiazide)

Alphabetical Index


Drug Information of CORZIDE

Product NDC: 60793-284
Proprietary Name: CORZIDE
Non Proprietary Name: nadolol and bendroflumethiazide
Active Ingredient(s): 5; 80    mg/1; mg/1 & nbsp;   nadolol and bendroflumethiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of CORZIDE

Product NDC: 60793-284
Labeler Name: King Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018647
Marketing Category: NDA
Start Marketing Date: 19830525

Package Information of CORZIDE

Package NDC: 60793-284-01
Package Description: 100 TABLET in 1 BOTTLE (60793-284-01)

NDC Information of CORZIDE

NDC Code 60793-284-01
Proprietary Name CORZIDE
Package Description 100 TABLET in 1 BOTTLE (60793-284-01)
Product NDC 60793-284
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name nadolol and bendroflumethiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19830525
Marketing Category Name NDA
Labeler Name King Pharmaceuticals, Inc.
Substance Name BENDROFLUMETHIAZIDE; NADOLOL
Strength Number 5; 80
Strength Unit mg/1; mg/1
Pharmaceutical Classes Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of CORZIDE


General Information